Plasma N-terminal pro-B-type natriuretic peptide concentration helps to predict survival in dogs with symptomatic degenerative mitral valve disease regardless of and in combination with the initial clinical status at admission

Journal of Veterinary Cardiology

Volumn 11, Issue 2, 2009, Pages 103-121

  Serres, François ^a   Pouchelon, Jean Louis ^a,b   Poujol, Laure ^a   Lefebvre, Hervé P ^c   Trumel, Cathy ^c   Daste, Thomas ^c   Sampedrano, Carolina Carlos ^a,b   Gouni, Vassiliki ^a   Tissier, Renaud ^a,b   Hawa, Gerhard ^d   Chetboul, Valérie ^a,b  

^a ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d Biomedica Gruppe   (Austria)

Author keywords

Canine; Doppler; Echocardiography; Heart; Natriuretic peptide

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTIARRHYTHMIC AGENT; BENAZEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; IMIDAPRIL; PIMOBENDAN; RAMIPRIL; SPIRONOLACTONE;

ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE SEVERITY; DOG; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HORMONE BLOOD LEVEL; MALE; MITRAL VALVE DISEASE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SURVIVOR; TREATMENT OUTCOME;

ANIMALS; CREATININE; DOG DISEASES; DOGS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART VALVE DISEASES; MALE; MITRAL VALVE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; UREA;

ANIMALIA; CANIS FAMILIARIS;

EID: 70450227361     PISSN: 17602734     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvc.2009.07.001     Document Type: Article

References (54)

1. Thrusfield M.V., Aiken C.G.C., and Darke P.G.G. Observations on breed and sex in relation to canine heart valve incompetence. J Small Anim Pract 26 (1985) 709-717
2. Kvart C., and Häggstrom J. Acquired valvular heart disease. In: Ettinger S.J., and Feldman E.C. (Eds). Textbook of veterinary internal medicine. 6th ed. (2005), WB Saunders, Philadelphia 1022-1039
3. Beardow A.W., and Buchanan J.W. Chronic mitral valve disease in Cavalier King Charles spaniels: 95 cases (1987-1991). J Am Vet Med Assoc 203 (1993) 1023-1029
4. Serfass P., Chetboul V., Carlos Sampedrano C., Nicolle A., Benalloul T., Laforge H., et al. Retrospective study of 942 small sized-dogs: prevalence of left apical systolic heart murmur and left-sided heart failure, critical effects of breed, and sex. J Vet Cardiol 8 (2006) 1-8
5. Kvart C., Häggström J., Pedersen H.D., Hansson K., Eriksson A., Järvinen A.K., et al. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation. J Vet Intern Med 16 (2002) 80-88
6. Atkins C.E., Keene B.W., Brown W.A., Coats J.R., Crawford M.A., De Francesco T.C., et al. Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency. J Am Vet Med Assoc 231 (2007) 1061-1069
7. Hamlin R.L. Prognostic value of changes in the cardiac silhouette in dogs with mitral insufficiency. J Am Vet Med Assoc 153 (1968) 1436-1445
8. Serres F., Chetboul V., Tissier R., Carlos Sampedrano C., Gouni V., Nicolle A.P., et al. Chordae tendinae rupture in dogs with degenerative mitral valve disease: prevalence, survival and prognostic factors (114 cases, 2001-2006). J Vet Intern Med 21 (2007) 258-264
9. Borgarelli M., Savarino P., Crosara S., Santilli A., Chiavegato D., Poggi M., et al. Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease. J Vet Intern Med 22 (2008) 120-128
10. Serres F., Chetboul V., Tissier R., Poujol L., Gouni V., Carlos Sampedrano C., et al. Comparison of 3 ultrasound methods for quantifying left ventricular systolic function: correlation with disease severity and prognostic value in dogs with mitral valve disease. J Vet Intern Med 22 (2008) 566-577
11. Schober K.E. Biochemical markers of cardiovascular disease. In: Ettinger S.J., and Feldman E.C. (Eds). Textbook of veterinary internal medicine. 6th ed. (2005), WB Saunders, Philadelphia 940-948
12. Abassi Z., Karram T., Ellaham S., Winaver J., and Hoffman A. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic. Pharmacol Ther 102 (2004) 223-241
13. Mueller T., Gegenhuber A., Poelz W., and Haltmayer M. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 91 (2005) 606-612
14. Bayes-Genis A., Lopez L., Zapico E., Cotes, Santalo M., Ordonez-Llanos J., et al. NT-proBNP reduction percentage during admission for acutely decompensated heart failure predicts long-term cardiovascular mortality. J Card Fail 11 (2005) S3-S8
15. Bayes-Genis A., Pascual-Figal D., Fabregat J., Domingo M., Planas F., Casas T., et al. Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure. Int J Cardiol 120 (2007) 338-343
16. Richards A.M., Nicholls M.G., Yandle T.G., Frampton C., Espiner E.A., Turner J.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular infarction. Circulation 97 (1998) 1921-1929
17. Bettencourt P., Azevedo A., Pimenta J., Frioes F., Ferreira S., and Perreira A. N-terminal pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110 (2004) 2168-2174
18. Oyama M.A., Fox P.R., and Rush J.E. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity. J Am Vet Med Assoc 232 (2008) 1496-1503
19. Fine D.M., Declue A.E., and Reinero C.R. Evaluation of circulating amino terminal-pro-B-type natriuretic peptide concentration in dogs with respiratory distress attributable to congestive heart failure or primary pulmonary disease. J Am Vet Med Assoc 232 (2008) 1674-1679
20. Boswood A., Dukes-McEwan J., Loureiro J., James R.A., Martin M., Stafford-Johnson M., et al. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease. J Small Anim Pract 49 (2008) 26-32
21. Hogenhuis J., Voors A.A., Jaarsma T., Hilleger H.L., Boomsma F., and Van Veldhuisen D.J. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP. Eur J Heart Fail 7 (2005) 81-86
22. Gouni V., Serres F.J., Pouchelon J.L., Tissier R., Lefebvre H.P., Nicolle A.P., et al. Quantification of mitral valve regurgitation in dogs with degenerative mitral valve disease by use of the proximal isovelocity surface area method. J Am Vet Med Assoc 231 (2007) 399-406
23. nd ed. (1999), WB Saunders, Philadelphia 883-901
24. Chetboul V., Athanassiadis N., Concordet D., Nicolle A.P., Tessier D., Castaignet M., et al. Observer-dependent variability of quantitative clinical endpoint: example of canine echocardiography. J Vet Pharmacol Ther 27 (2004) 49-56
25. Chetboul V., Carlos Sampedrano C., Concordet D., Tissier R., Lamour T., Ginesta J., et al. Use of quantitative two-dimensional color tissue Doppler imaging for assessment of left ventricular radial and longitudinal myocardial velocities in dogs. Am J Vet Res 66 (2005) 953-961
26. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
27. Cornell C.C., Kittleson M.D., Della Torre P., Häggström J., Lombard C.W., Pedersen H.D., et al. Allometric scaling of M-mode cardiac measurements in normal adult dogs. J Vet Intern Med 18 (2004) 311-321
28. Appendix in Kirk's current veterinary therapy. Small animal practice. volume XIII. Bonagura JD, editor. 2000.
29. Serres F.J., Chetboul V., Tissier R., Gouni V., Carlos Sampedrano C., Nicolle A.P., et al. Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001-2005). J Am Vet Med Assoc 229 (2006) 1772-1778
30. Polzin D.J., Osborne C.A., and Ross S. Chronic kidney failure. In: Ettinger S.J., and Feldman E.C. (Eds). Textbook of veterinary internal medicine. 6th ed. (2005), WB Saunders, Philadelphia 1756-1785
31. Prosek R., Sisson D.D., Oyama M.A., and Solter P.F. Distinguishing cardiac and noncardiac dyspnea in 48 dogs using plasma atrial natriuretic factor, B-type natriuretic factor, endothelin, and cardiac troponin-I. J Vet Intern Med 21 (2007) 238-242
32. DeFranceso T.C., Rush J.E., Rozanski E.A., Hansen B.D., Keene B.W., Moore D.T., et al. Prospective clinical evaluation of an ELISA B-Type natriuretic peptide assay in the diagnosis of congestive heart failure in dogs presenting with cough or dyspnea. J Vet Intern Med 21 (2007) 243-250
33. Eriksson A.S., Järvinen A.K., Eklund K.K., Vuolteenaho O.J., Toivari M.H., and Nieminen M.S. Effect of age and body weight on neurohumoral variables in healthy Cavalier King Charles Spaniels. Am J Vet Res 62 (2001) 1818-1824
34. Häggström J., Hansson K., and Kvart C. Relationship between different natriuretic peptides and severity of naturally acquired mitral regurgitation in dogs with chronic myxomatous valve disease. J Vet Cardiol 2 (2000) 7-16
35. Häggström J., Hansson K., Karlberg B.E., Kvart C., and Olson K. Plasma concentration of atrial natriuretic peptide in relation to severity of mitral regurgitation in Cavalier King Charles Spaniels. Am J Vet Res 55 (1994) 698-703
36. Häggström J., Hansson K., Kvart C., Karlberg B.E., Vuolteenaho O., and Olson K. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs. Am J Vet Res 58 (1997) 77-82
37. Connolly D.J., Soares Magalhaes R.J., Syme H.M., Boswood A., Luis Fuentes V., Chu L., et al. Circulating natriuretic peptides in cats with heart disease. J Vet Intern Med 22 (2008) 96-105
38. MacDonald K.A., Kittleson M.D., Munro C., and Kass P. Brain natriuretic peptide concentration in dogs with heart disease and congestive heart failure. J Vet Intern Med 17 (2003) 172-177
39. Greco D.S., Biller B., and Van Liew C.H. Measurement of plasma atrial natriuretic peptide as an indicator of prognosis in dogs with cardiac disease. Can Vet J 44 (2003) 293-297
40. Chetboul V., Tessier-Vetzel D., Escriou C., Tissier, Carlos Sampedrano C., Boussouf M., et al. Diagnostic potential of natriuretic peptides in the occult phase of golden retriever muscular dystrophy cardiomyopathy. J Vet Intern Med 18 (2004) 845-850
41. Tarnow I., Olsen L.H., Kvart C., Hoglund K., Moesgaard S.G., Kamstrup T.S., et al. Predictive value of natriuretic peptides in dogs with mitral valve disease. Vet J (2008, Jul 31) (Epub ahead of print)
42. Costello-Boerrigter L.C., Boerrigter G., Redfield M.M., Rodeheffer R.J., Urban L.H., Mahoney D.W., et al. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community. J Am Coll Cardiol 47 (2006) 345-353
43. The BENCH (BENazepril in Canine Heart disease) Study Group. The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial. J Vet Cardiol 1 (1999) 7-18
44. Ettinger S.J., Benitz A.M., Ericsson G.F., Cifelli S., Jernigan A.D., Longhofer S.L., et al. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The long-term investigation of veterinary enalapril (LIVE) study group. J Am Vet Med Assoc 213 (1998) 1573-1577
45. Lombard C.W., Jöns O., and Bussadori C.M. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. J Am Anim Hosp Assoc 42 (2006) 249-261
46. Häggström J., Boswood A., O'Grady M., Jöns O., Smith S., Swift S., et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. J Vet Intern Med 22 (2008) 1124-1135
47. Nagaya N., Nishikimi T., Okano Y., Uematsu M., Satoh T., Kyotani S., et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 31 (1998) 202-208
48. Passino C., Maria Sironi A., Favilli B., Poletti R., Prontera C., Ripoli A., et al. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. Int J Cardiol 104 (2005) 39-45
49. Serres F., Chetboul V., Gouni V., Tissier R., Carlos Sampedrano C., and Pouchelon J.L. Diagnostic value of echo-Doppler and tissue Doppler imaging in dogs with pulmonary arterial hypertension. J Vet Intern Med 21 (2007) 1280-1289
50. Nicolle A.P., Chetboul V., Allerheiligen T., Pouchelon J.L., Gouni V., Tessier-Vetzel D., et al. Azotemia and glomerular filtration rate in dogs with chronic valvular disease. J Vet Intern Med 21 (2007) 943-949
51. Throughton R.W., Framton C.M., Yandle T.G., Espiner E.A., Nicholls M.G., and Richards A.M. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355 (2000) 1126-1130
52. Jourdain P., Jondeau G., Funck F., Gueffet P., Le Helloco A., Donal E., et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP multicenter study. J Am Coll Cardiol 49 (2007) 1733-1739
53. Morrow D.A., and de Lemos J.A. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 115 (2007) 949-952
54. Boswood A., and Murphy A. The effect of heart disease, heart failure and diuresis on selected laboratory and electrocardiographic parameters in dogs. J Vet Cardiol 8 (2006) 1-9